Share Price and Basic Stock Data
Last Updated: October 29, 2025, 8:21 pm
| PEG Ratio | 0.88 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Balmer Lawrie & Company Ltd, operating in the diversified sector, reported a sales figure of ₹2,312 Cr for the financial year ending March 2023, a notable increase from ₹2,051 Cr in March 2022. The company’s revenue for the TTM stood at ₹2,558 Cr. Quarterly sales fluctuated, with the highest recorded in March 2025 at ₹681 Cr and the lowest in December 2022 at ₹514 Cr. The sales figures indicate a positive trajectory, particularly with Q1 FY 2025 showing a robust performance of ₹681 Cr, up from ₹648 Cr in Q1 FY 2024. The company’s operating profit margin (OPM) also demonstrated resilience, recorded at 12% for the last reported period, with a peak of 16% in March 2024, showcasing effective cost management amid varying sales figures. The sales performance reflects Balmer Lawrie’s ability to navigate market challenges, positioning itself favorably within the industry.
Profitability and Efficiency Metrics
Balmer Lawrie reported a net profit of ₹264 Cr for the financial year ending March 2025, up from ₹168 Cr in March 2023, indicating a solid growth trajectory. The net profit margin stood at 7.74% for March 2025, a slight decrease from 8.52% in the previous year, but still within a competitive range for the diversified sector. The return on equity (ROE) was recorded at 14.0%, reflecting a strong capacity to generate returns for shareholders, while the return on capital employed (ROCE) was at 14.8%. The interest coverage ratio (ICR) of 13.67x demonstrates Balmer Lawrie’s robust ability to meet interest obligations. The company’s operating profit increased to ₹313 Cr in March 2025, up from ₹202 Cr in March 2023, indicating improved operational efficiency. These profitability metrics underscore Balmer Lawrie’s effective management strategies in enhancing margins and returns, positioning it well against industry norms.
Balance Sheet Strength and Financial Ratios
Balmer Lawrie’s balance sheet exhibited strength with total assets amounting to ₹3,040 Cr as of March 2025, an increase from ₹2,873 Cr in March 2024. The company maintained a conservative borrowing level, with total borrowings recorded at ₹106 Cr, reflecting a low debt-to-equity ratio of 0.03, which is favorable compared to sector averages. The company’s reserves stood at ₹1,798 Cr, providing a solid cushion for future investments and operational stability. The current ratio of 2.27 and quick ratio of 1.99 indicate strong liquidity positions, ensuring that the company can meet its short-term obligations comfortably. Furthermore, the price-to-book value (P/BV) ratio of 1.60x suggests that the stock is trading at a reasonable valuation, compared to typical sector metrics. This balance sheet strength positions Balmer Lawrie favorably to capitalize on growth opportunities while managing risks effectively.
Shareholding Pattern and Investor Confidence
As of March 2025, Balmer Lawrie’s shareholding pattern reflects a diverse ownership structure, with public shareholders holding 95.94%, while foreign institutional investors (FIIs) accounted for 2.26% and domestic institutional investors (DIIs) at 1.79%. The number of shareholders increased to 1,11,490, indicating growing investor interest and confidence in the company’s performance. The slight increase in FII participation from 1.20% in March 2023 to 2.26% in March 2025 demonstrates a positive outlook from foreign investors, aligning with the company’s robust financial metrics. However, the relatively low institutional ownership may suggest potential volatility, as the company is predominantly held by retail investors. This investor confidence, coupled with a consistent dividend payout ratio of 55% for March 2025, reflects Balmer Lawrie’s commitment to returning value to shareholders, fostering a stable investment environment.
Outlook, Risks, and Final Insight
The outlook for Balmer Lawrie remains cautiously optimistic, bolstered by a solid financial performance and a growing market presence. However, the company faces risks, including fluctuations in commodity prices and potential supply chain disruptions, which could impact profit margins. Moreover, with a significant reliance on domestic markets, any economic downturn could adversely affect sales. The increase in quarterly sales figures suggests resilience, but maintaining this momentum will be crucial. The company’s strong balance sheet and liquidity position provide a buffer against short-term challenges, while its operational efficiencies could drive future growth. Should Balmer Lawrie effectively navigate these risks while leveraging its strengths, it may continue to enhance its market position and deliver value to shareholders in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balmer Lawrie & Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 9,569 Cr. | 1,361 | 1,639/842 | 23.8 | 373 | 0.48 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 20,759 Cr. | 1,330 | 1,502/903 | 29.1 | 463 | 0.68 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,478 Cr. | 203 | 253/147 | 12.8 | 115 | 4.18 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 33,589 Cr. | 29,765 | 37,134/25,714 | 54.9 | 1,906 | 0.54 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 16,848.75 Cr | 8,164.75 | 30.15 | 714.25 | 1.47% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 648 | 551 | 514 | 608 | 592 | 586 | 585 | 577 | 638 | 639 | 630 | 608 | 681 |
| Expenses | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 546 | 514 | 597 |
| Operating Profit | 61 | 39 | 50 | 52 | 65 | 75 | 74 | 91 | 64 | 70 | 84 | 95 | 83 |
| OPM % | 9% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 13% | 16% | 12% |
| Other Income | 8 | 8 | 3 | 17 | 10 | 13 | 11 | 18 | 12 | 11 | 9 | 18 | 9 |
| Interest | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 | 14 |
| Profit before tax | 51 | 29 | 34 | 51 | 54 | 69 | 64 | 88 | 56 | 62 | 68 | 90 | 71 |
| Tax % | 22% | 37% | 29% | 51% | 22% | 31% | 24% | 31% | 20% | 30% | 29% | 35% | 27% |
| Net Profit | 55 | 34 | 35 | 43 | 56 | 63 | 66 | 73 | 63 | 61 | 62 | 74 | 67 |
| EPS in Rs | 3.28 | 2.05 | 2.11 | 2.61 | 3.35 | 3.73 | 3.90 | 4.31 | 3.73 | 3.66 | 3.77 | 4.39 | 4.03 |
Last Updated: August 20, 2025, 1:10 pm
Below is a detailed analysis of the quarterly data for Balmer Lawrie & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 681.00 Cr.. The value appears strong and on an upward trend. It has increased from 608.00 Cr. (Mar 2025) to 681.00 Cr., marking an increase of 73.00 Cr..
- For Expenses, as of Jun 2025, the value is 597.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 597.00 Cr., marking an increase of 83.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 12.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 71.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 71.00 Cr., marking a decrease of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to 27.00%, marking a decrease of 8.00%.
- For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.03. The value appears to be declining and may need further review. It has decreased from 4.39 (Mar 2025) to 4.03, marking a decrease of 0.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,120 | 3,254 | 1,591 | 1,702 | 1,720 | 1,772 | 1,532 | 1,526 | 2,051 | 2,312 | 2,328 | 2,505 | 2,558 |
| Expenses | 2,908 | 3,031 | 1,386 | 1,492 | 1,502 | 1,539 | 1,342 | 1,385 | 1,882 | 2,109 | 2,023 | 2,192 | 2,226 |
| Operating Profit | 212 | 223 | 205 | 211 | 219 | 233 | 189 | 141 | 169 | 202 | 305 | 313 | 332 |
| OPM % | 7% | 7% | 13% | 12% | 13% | 13% | 12% | 9% | 8% | 9% | 13% | 12% | 13% |
| Other Income | 70 | 64 | 63 | 56 | 51 | 51 | 51 | 49 | 37 | 37 | 51 | 50 | 47 |
| Interest | 24 | 23 | 5 | 5 | 4 | 7 | 15 | 12 | 14 | 18 | 22 | 27 | 27 |
| Depreciation | 35 | 46 | 24 | 26 | 27 | 30 | 52 | 55 | 57 | 57 | 59 | 60 | 60 |
| Profit before tax | 222 | 218 | 240 | 236 | 238 | 247 | 173 | 123 | 136 | 164 | 274 | 276 | 292 |
| Tax % | 30% | 30% | 32% | 34% | 31% | 35% | 32% | 33% | 35% | 35% | 27% | 29% | |
| Net Profit | 156 | 152 | 164 | 155 | 165 | 197 | 155 | 115 | 134 | 168 | 236 | 259 | 264 |
| EPS in Rs | 9.09 | 8.89 | 9.58 | 9.05 | 9.66 | 11.65 | 9.43 | 7.04 | 8.05 | 10.05 | 14.02 | 15.55 | 15.85 |
| Dividend Payout % | 27% | 34% | 35% | 52% | 69% | 63% | 80% | 85% | 81% | 75% | 61% | 55% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2.56% | 7.89% | -5.49% | 6.45% | 19.39% | -21.32% | -25.81% | 16.52% | 25.37% | 40.48% | 9.75% |
| Change in YoY Net Profit Growth (%) | 0.00% | 10.46% | -13.38% | 11.94% | 12.94% | -40.71% | -4.49% | 42.33% | 8.85% | 15.10% | -30.73% |
Balmer Lawrie & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | 7% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 25% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:25 am
Balance Sheet
Last Updated: June 16, 2025, 12:25 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 114 | 114 | 114 | 171 | 171 | 171 | 171 | 171 | 171 |
| Reserves | 953 | 1,015 | 1,210 | 1,247 | 1,342 | 1,406 | 1,383 | 1,371 | 1,416 | 1,510 | 1,650 | 1,798 |
| Borrowings | 175 | 197 | 0 | 0 | 15 | 81 | 120 | 125 | 122 | 121 | 113 | 106 |
| Other Liabilities | 724 | 670 | 559 | 669 | 720 | 682 | 660 | 712 | 736 | 860 | 939 | 966 |
| Total Liabilities | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 |
| Fixed Assets | 464 | 577 | 393 | 397 | 410 | 568 | 770 | 767 | 767 | 760 | 751 | 737 |
| CWIP | 77 | 12 | 11 | 63 | 138 | 117 | 24 | 32 | 11 | 28 | 52 | 67 |
| Investments | 0 | 0 | 248 | 271 | 293 | 325 | 375 | 386 | 436 | 518 | 565 | 632 |
| Other Assets | 1,339 | 1,322 | 1,146 | 1,299 | 1,350 | 1,272 | 1,165 | 1,194 | 1,231 | 1,356 | 1,505 | 1,604 |
| Total Assets | 1,880 | 1,911 | 1,798 | 2,030 | 2,191 | 2,282 | 2,334 | 2,379 | 2,445 | 2,662 | 2,873 | 3,040 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 171.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 171.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,798.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,650.00 Cr. (Mar 2024) to 1,798.00 Cr., marking an increase of 148.00 Cr..
- For Borrowings, as of Mar 2025, the value is 106.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2024) to 106.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 966.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 939.00 Cr. (Mar 2024) to 966.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,040.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,873.00 Cr. (Mar 2024) to 3,040.00 Cr., marking an increase of 167.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to 737.00 Cr., marking a decrease of 14.00 Cr..
- For CWIP, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 15.00 Cr..
- For Investments, as of Mar 2025, the value is 632.00 Cr.. The value appears strong and on an upward trend. It has increased from 565.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 67.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,604.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,505.00 Cr. (Mar 2024) to 1,604.00 Cr., marking an increase of 99.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,040.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,873.00 Cr. (Mar 2024) to 3,040.00 Cr., marking an increase of 167.00 Cr..
Notably, the Reserves (1,798.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 37.00 | 26.00 | 205.00 | 211.00 | 204.00 | 152.00 | 69.00 | 16.00 | 47.00 | 81.00 | 192.00 | 207.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 53 | 53 | 60 | 57 | 57 | 65 | 69 | 56 | 57 | 67 | 70 |
| Inventory Days | 48 | 48 | 77 | 51 | 46 | 47 | 57 | 59 | 51 | 46 | 66 | 67 |
| Days Payable | 53 | 44 | 144 | 104 | 108 | 96 | 88 | 100 | 69 | 68 | 108 | 104 |
| Cash Conversion Cycle | 57 | 56 | -14 | 8 | -4 | 8 | 35 | 28 | 38 | 35 | 25 | 33 |
| Working Capital Days | 23 | 23 | -24 | 30 | 39 | 44 | 49 | 30 | 49 | 39 | 39 | 62 |
| ROCE % | 22% | 20% | 20% | 18% | 17% | 16% | 11% | 8% | 8% | 10% | 16% | 15% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 92,092 | 0.26 | 2.25 | 92,092 | 2025-04-22 17:25:41 | 0% |
| Groww Nifty Total Market Index Fund | 394 | 0.01 | 0.01 | 394 | 2025-04-22 17:25:41 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Diluted EPS (Rs.) | 15.55 | 15.30 | 10.05 | 8.07 | 7.04 |
| Cash EPS (Rs.) | 14.92 | 15.11 | 9.57 | 8.49 | 8.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 115.12 | 108.06 | 100.11 | 94.94 | 92.46 |
| Revenue From Operations / Share (Rs.) | 147.11 | 136.79 | 135.76 | 120.19 | 89.41 |
| PBDIT / Share (Rs.) | 21.20 | 20.80 | 13.98 | 12.06 | 11.09 |
| PBIT / Share (Rs.) | 17.68 | 17.34 | 10.66 | 8.79 | 7.88 |
| PBT / Share (Rs.) | 16.13 | 16.05 | 9.61 | 8.00 | 7.18 |
| Net Profit / Share (Rs.) | 11.39 | 11.65 | 6.25 | 5.23 | 4.83 |
| NP After MI And SOA / Share (Rs.) | 15.55 | 15.30 | 10.05 | 7.88 | 6.74 |
| PBDIT Margin (%) | 14.41 | 15.20 | 10.29 | 10.03 | 12.40 |
| PBIT Margin (%) | 12.01 | 12.67 | 7.85 | 7.31 | 8.80 |
| PBT Margin (%) | 10.96 | 11.73 | 7.07 | 6.65 | 8.03 |
| Net Profit Margin (%) | 7.74 | 8.52 | 4.60 | 4.35 | 5.40 |
| NP After MI And SOA Margin (%) | 10.57 | 11.18 | 7.40 | 6.55 | 7.54 |
| Return on Networth / Equity (%) | 13.50 | 14.36 | 10.22 | 8.48 | 7.47 |
| Return on Capital Employeed (%) | 12.90 | 13.71 | 9.02 | 7.83 | 7.27 |
| Return On Assets (%) | 8.74 | 9.10 | 6.45 | 5.50 | 4.84 |
| Long Term Debt / Equity (X) | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 |
| Total Debt / Equity (X) | 0.03 | 0.04 | 0.05 | 0.05 | 0.06 |
| Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.90 | 0.94 | 0.71 |
| Current Ratio (X) | 2.27 | 2.08 | 2.09 | 2.31 | 2.24 |
| Quick Ratio (X) | 1.99 | 1.81 | 1.77 | 1.93 | 1.94 |
| Inventory Turnover Ratio (X) | 13.04 | 5.07 | 7.88 | 5.34 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 54.65 | 49.03 | 64.67 | 76.14 | 111.23 |
| Dividend Payout Ratio (CP) (%) | 44.55 | 39.98 | 48.61 | 53.84 | 75.30 |
| Earning Retention Ratio (%) | 45.35 | 50.97 | 35.33 | 23.86 | -11.23 |
| Cash Earning Retention Ratio (%) | 55.45 | 60.02 | 51.39 | 46.16 | 24.70 |
| Interest Coverage Ratio (X) | 13.67 | 16.13 | 13.33 | 15.17 | 15.92 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 10.04 | 6.96 | 7.58 | 7.93 |
| Enterprise Value (Cr.) | 2796.58 | 3661.98 | 1567.62 | 1642.42 | 1805.18 |
| EV / Net Operating Revenue (X) | 1.11 | 1.57 | 0.67 | 0.79 | 1.18 |
| EV / EBITDA (X) | 7.71 | 10.30 | 6.56 | 7.97 | 9.51 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| Retention Ratios (%) | 45.34 | 50.96 | 35.32 | 23.85 | -11.23 |
| Price / BV (X) | 1.60 | 2.24 | 1.13 | 1.21 | 1.43 |
| Price / Net Operating Revenue (X) | 1.26 | 1.75 | 0.81 | 0.93 | 1.44 |
| EarningsYield | 0.08 | 0.06 | 0.09 | 0.06 | 0.05 |
After reviewing the key financial ratios for Balmer Lawrie & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.92. This value is within the healthy range. It has decreased from 15.11 (Mar 24) to 14.92, marking a decrease of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 115.12. It has increased from 108.06 (Mar 24) to 115.12, marking an increase of 7.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 147.11. It has increased from 136.79 (Mar 24) to 147.11, marking an increase of 10.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.20. This value is within the healthy range. It has increased from 20.80 (Mar 24) to 21.20, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 17.34 (Mar 24) to 17.68, marking an increase of 0.34.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.13. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 16.13, marking an increase of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.39. This value is within the healthy range. It has decreased from 11.65 (Mar 24) to 11.39, marking a decrease of 0.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.55. This value is within the healthy range. It has increased from 15.30 (Mar 24) to 15.55, marking an increase of 0.25.
- For PBDIT Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.20 (Mar 24) to 14.41, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 12.01, marking a decrease of 0.66.
- For PBT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 10.96, marking a decrease of 0.77.
- For Net Profit Margin (%), as of Mar 25, the value is 7.74. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.74, marking a decrease of 0.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.57, marking a decrease of 0.61.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.50. This value is below the healthy minimum of 15. It has decreased from 14.36 (Mar 24) to 13.50, marking a decrease of 0.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has decreased from 13.71 (Mar 24) to 12.90, marking a decrease of 0.81.
- For Return On Assets (%), as of Mar 25, the value is 8.74. This value is within the healthy range. It has decreased from 9.10 (Mar 24) to 8.74, marking a decrease of 0.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has increased from 0.84 (Mar 24) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 2.08 (Mar 24) to 2.27, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 1.99, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.04. This value exceeds the healthy maximum of 8. It has increased from 5.07 (Mar 24) to 13.04, marking an increase of 7.97.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.65. This value exceeds the healthy maximum of 50. It has increased from 49.03 (Mar 24) to 54.65, marking an increase of 5.62.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 44.55. This value is within the healthy range. It has increased from 39.98 (Mar 24) to 44.55, marking an increase of 4.57.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.35. This value is within the healthy range. It has decreased from 50.97 (Mar 24) to 45.35, marking a decrease of 5.62.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 55.45. This value is within the healthy range. It has decreased from 60.02 (Mar 24) to 55.45, marking a decrease of 4.57.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 16.13 (Mar 24) to 13.67, marking a decrease of 2.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has decreased from 10.04 (Mar 24) to 8.34, marking a decrease of 1.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,796.58. It has decreased from 3,661.98 (Mar 24) to 2,796.58, marking a decrease of 865.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.11, marking a decrease of 0.46.
- For EV / EBITDA (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 7.71, marking a decrease of 2.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 45.34. This value is within the healthy range. It has decreased from 50.96 (Mar 24) to 45.34, marking a decrease of 5.62.
- For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.24 (Mar 24) to 1.60, marking a decrease of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.26, marking a decrease of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.08, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie & Company Ltd:
- Net Profit Margin: 7.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.9% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.5% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.8 (Industry average Stock P/E: 30.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Diversified | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | bhavsar.k@balmerlawrie.com http://www.balmerlawrie.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Adhip Nath Palchaudhuri | Chairman & Managing Director |
| Mr. Saurav Dutta | Director - Finance & CFO |
| Dr. Vandana Minda Heda | Independent Director |
| Mr. Rajeev Kumar | Government Nominee Director |
| Mr. Raja Mani Uthayaraja | Director |
| Mr. Abhijit Ghosh | Director |
| Mr. Romon Sebastian Louis | Director |
| Mr. Harishkumar Madhusudan Joshi | Independent Director |
FAQ
What is the intrinsic value of Balmer Lawrie & Company Ltd?
Balmer Lawrie & Company Ltd's intrinsic value (as of 29 October 2025) is 171.76 which is 15.39% lower the current market price of 203.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,478 Cr. market cap, FY2025-2026 high/low of 253/147, reserves of ₹1,798 Cr, and liabilities of 3,040 Cr.
What is the Market Cap of Balmer Lawrie & Company Ltd?
The Market Cap of Balmer Lawrie & Company Ltd is 3,478 Cr..
What is the current Stock Price of Balmer Lawrie & Company Ltd as on 29 October 2025?
The current stock price of Balmer Lawrie & Company Ltd as on 29 October 2025 is 203.
What is the High / Low of Balmer Lawrie & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie & Company Ltd stocks is 253/147.
What is the Stock P/E of Balmer Lawrie & Company Ltd?
The Stock P/E of Balmer Lawrie & Company Ltd is 12.8.
What is the Book Value of Balmer Lawrie & Company Ltd?
The Book Value of Balmer Lawrie & Company Ltd is 115.
What is the Dividend Yield of Balmer Lawrie & Company Ltd?
The Dividend Yield of Balmer Lawrie & Company Ltd is 4.18 %.
What is the ROCE of Balmer Lawrie & Company Ltd?
The ROCE of Balmer Lawrie & Company Ltd is 14.8 %.
What is the ROE of Balmer Lawrie & Company Ltd?
The ROE of Balmer Lawrie & Company Ltd is 14.0 %.
What is the Face Value of Balmer Lawrie & Company Ltd?
The Face Value of Balmer Lawrie & Company Ltd is 10.0.